Automated Computer Tool Designs Ring-Shaped Drug Molecules From Small Molecules to Proteins

The automated platform successfully generates and ranks macrocyclic designs across molecular scales, from small molecules through peptides to PROTACs and proteins, using established chemical reactions and reagents.

Computational approach using 3D protein-ligand structures as input, automated linker generation from a reaction library, geometric compatibility evaluation, and ranking by conformational stability. Validated with prospective and retrospective case studies.

Ring-shaped molecules often make better drugs than their linear counterparts — they bind more tightly, resist enzymatic breakdown, and can penetrate cells more easily. Automating their design could dramatically accelerate drug development timelines.

As computational drug design tools become more sophisticated, the bottleneck in drug development shifts from molecular design to clinical testing. Automated macrocyclization could make previously "undruggable" targets accessible to peptide and small molecule therapeutics.

Computational predictions of binding and stability require experimental validation. The tool relies on known chemical reactions, potentially missing novel cyclization strategies. Manufacturing feasibility of proposed designs is not assessed.